Herbert Weissbach

Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ.

CHS Pharma, Inc. commercializes treatment for skin pre-cancerous disorders. It provides treatment and prevention for skin condition commonly known as Actinic Keratosis. The company was founded by Stephen Chakoff and Herbert Weissbach and is headquartered Jupiter, FL.